Skip to main content
TipRanks
Go Ultimate75% OFF

Immucell (ICCC) Q4 2019 Earnings Report

81 Followers

ICCC Q4 2019 EPS Results

Actual EPS
-$0.06
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.19

ICCC Q4 2019 Revenue Results

Actual Revenue
$3.63M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+23.66%

Earnings Announcement Details

Quarter
Q4 2019
Date
02/18/2020
Time
After Close
Conference Call
Tuesday, February 18, 2020

Q4 2019 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2019 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2019 Earnings Call Summary

No earnings call summary is available for this earnings event.

ICCC Earnings History

ICCC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 12, 20262026 (Q3)―--0.01―
Aug 13, 20262026 (Q2)―0.200.06257.14% (+0.14)
May 14, 20262026 (Q1)―0.210.1633.54% (+0.05)
Mar 04, 20262025 (Q4)―-0.320.06-643.10% (-0.37)
Nov 13, 20252025 (Q3)―-0.01-0.0982.56% (+0.07)
Aug 14, 20252025 (Q2)―0.06-0.2128.57% (+0.25)
May 14, 20252025 (Q1)―0.16-0.06387.50% (+0.22)
Feb 25, 20252024 (Q4)―0.06-0.15139.46% (+0.20)
Nov 13, 20242024 (Q3)―-0.09-0.1228.93% (+0.04)
Aug 13, 20242024 (Q2)―-0.20-0.18-10.11% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed